Online citations, reference lists, and bibliographies.

Expression And Characterization Of The Two Outer Capsid Proteins Of African Horsesickness Virus: The Role Of VP2 In Virus Neutralization.

J. Martínez-Torrecuadrada, H. Iwata, Á. Venteo, I. Casal, P. Roy
Published 1994 · Biology, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
African horsesickness virus (AHSV) is a gnat-transmitted member of the Orbivirus genus of the Reoviridae family. The virus has a genome of 10 double-stranded RNA species (L1-L3, M4-M6, S7-S10). The L2 and M6 genes of AHSV serotype 4 (AHSV-4) which encode the outer capsid proteins VP2 and VP5, respectively, were inserted into recombinant baculoviruses downstream of the baculovirus polyhedrin, or p10 promoters. Recombinant baculoviruses expressing VP2, VP5, or VP2 and VP5 proteins of AHSV-4 were isolated. The expressed AHSV proteins were similar in size and antigenic properties to those of viral AHSV-4. Expressed VP2 and VP5 proteins were purified to homogeneity and utilized to differentiate sera from vaccinated and infected horses. Antigens were also used to determine whether any other AHSV serotypes are related to AHSV-4. The results indicated that AHSV-4 is distantly related to some serotypes (e.g., AHSV-2, -6, and -9) but not to others (e.g., AHSV-5 and -7). Hyperimmune monospecific antisera raised in rabbits with purified VP2 neutralized the infectivity of a virulent strain of AHSV-4 isolated from an infected horse during a recent outbreak of the disease in Spain.



This paper is referenced by
10.1128/CDLI.7.4.645-651.2000
Antigenic Properties and Diagnostic Potential of Baculovirus-Expressed Infectious Bursal Disease Virus Proteins VPX and VP3
J. Martínez-Torrecuadrada (2000)
Recombinant baculovirus-synthesized African horsesickness virus ( AHSV ) outer-capsid protein VP 2 provides protection against virulent AHSV challenge
L. H. (2007)
10.1128/JVI.01328-16
Structural Protein VP2 of African Horse Sickness Virus Is Not Essential for Virus Replication In Vitro
René G. P. van Gennip (2016)
Silencing African horsesickness virus VP7 protein expression in vitro by RNA interference
L. Burger (2008)
Identifying B-cell epitopes of African horse sickness virus serotype 4 recognised by antisera of immunised horses
E. M. Mathebula (2016)
10.1016/j.jviromet.2019.01.016
Using a new serotype-specific Polymerase Chain Reaction (PCR) and sequencing to differentiate between field and vaccine-derived African Horse Sickness viruses submitted in 2016/2017.
Antoinette van Schalkwyk (2019)
10.1099/0022-1317-77-9-2053
Recombinant baculovirus-synthesized African horsesickness virus (AHSV) outer-capsid protein VP2 provides protection against virulent AHSV challenge.
P. Roy (1996)
10.1016/j.vaccine.2018.09.065
A single dose of African horse sickness virus (AHSV) VP2 based vaccines provides complete clinical protection in a mouse model
Mine Aksular (2018)
10.1099/VIR.0.18919-0
A first full outer capsid protein sequence data-set in the Orbivirus genus (family Reoviridae): cloning, sequencing, expression and analysis of a complete set of full-length outer capsid VP2 genes of the nine African horsesickness virus serotypes.
A. Potgieter (2003)
Suppression of African horse sickness virus NS1 protein expression in mammalian cells by short hairpin RNAs
Helena Roos (2009)
10.1186/s12917-018-1554-5
Sero-epidemioloical survey on African horse sickness virus among horses in Khartoum State, Central Sudan
Siham T Karamalla (2018)
Cloning viral dsRNA genomes : analysis and application
A. Potgieter (2004)
10.1016/j.vetimm.2012.06.009
An African horse sickness virus serotype 4 recombinant canarypox virus vaccine elicits specific cell-mediated immune responses in horses.
H. El Garch (2012)
10.1099/0022-1317-82-10-2415
Definition of neutralizing sites on African horse sickness virus serotype 4 VP2 at the level of peptides.
J. Martínez-Torrecuadrada (2001)
10.1099/vir.0.000124
Virus uncoating is required for apoptosis induction in cultured mammalian cells infected with African horse sickness virus.
E. Vermaak (2015)
Immune responses in a horse inoculated with the VP2 gene of African horsesickness virus.
M. Romito (1999)
Recombinant baculovirus-synthesized African horsesickness virus ( AHSV ) outer-capsid protein VP 2 provides protection against virulent AHSV challenge
L. H. (2007)
10.1016/j.vaccine.2014.07.031
Immunogenicity of recombinant VP2 proteins of all nine serotypes of African horse sickness virus
Y. Kanai (2014)
The characterization of inner core protein VP6 of African horsesickness virus
De Waal (2007)
Protein aggregation complicates the development of baculovirus-expressed African horsesickness virus serotype 5 VP2 subunit vaccines.
M. du Plessis (1998)
10.4142/jvs.2013.14.1.95
Serotype- and serogroup-specific detection of African horsesickness virus using phage displayed chicken scFvs for indirect double antibody sandwich ELISAs
W. van Wyngaardt (2013)
Recombinant baculovirus-synthesized African horsesickness virus ( AHSV ) outer-capsid protein VP 2 provides protection against virulent AHSV challenge
L. H. (2007)
10.1186/s12917-019-2184-2
Plant-produced chimeric virus-like particles - a new generation vaccine against African horse sickness
Daria A. Rutkowska (2019)
Identification and expression of proteases C. sonorensis and C. imicola important for African horsesickness virus replication
Van Vuuren (2014)
10.1016/j.virusres.2015.12.006
Synthesis of empty african horse sickness virus particles.
S. Maree (2016)
Silencing of African horse sickness virus NS2 gene expression using vector-derived short hairpin RNAs
Marthi Nieuwoudt (2010)
Characterization and sequence variation of the virulence-associated proteins of different tissue culture isolates of African Horsesickness virus serotype 4
J. Korsman (2007)
10.1016/j.pep.2013.07.005
Multiple large foreign protein expression by a single recombinant baculovirus: a system for production of multivalent vaccines.
Y. Kanai (2013)
Cloning viral dsRNA genomes : Analysis and application
C. A. (2004)
Mapping the function of the NS3 protein of African horsesickness virus using RNAi and yeast two-hybrid analyses
W. Barnes (2011)
10.1007/978-3-7091-6823-3_17
New generation of African horse sickness virus vaccines based on structural and molecular studies of the virus particles.
P. Roy (1998)
10.1099/0022-1317-77-6-1211
Full protection against African horsesickness (AHS) in horses induced by baculovirus-derived AHS virus serotype 4 VP2, VP5 and VP7.
J. Martínez-Torrecuadrada (1996)
See more
Semantic Scholar Logo Some data provided by SemanticScholar